AMES, Iowa – Laboratory video tells the story: tiny, parasitic worms swimming freely in a nutrient solution are active and mobile; expose the same kind of worms to a mixture of four drugs optimized by ...

When disease outbreaks happen, response time in developing and distributing treatments is crucial to saving lives. Unfortunately, developing custom drugs as countermeasures is often a slow and ...

Thanks to modern therapies, a cancer diagnosis is no longer an automatic death sentence. But many patients still suffer from ...

Explore the evolution of T-cell engagers, from experimental concepts to effective therapies for haematologic malignancies.

SAN DIEGO--(BUSINESS WIRE)--Ablexis, LLC (“Ablexis”), a biopharmaceutical company focused on licensing its AlivaMab ® Mouse technology for antibody drug discovery, and AlivaMab Discovery Services, LLC ...

(BOSTON) - A new strategy for engineering protein fusions -- to make specific cell-targeted drugs without side effects -- could enable a safer, more potent class of protein drugs. A team at the Wyss ...

Dr. Kidochukwu Atube is among a rising group of Nigerian scientists whose work spans engineering, pharmaceutical sciences and immunology, earning him growing international recognition. Recent ...

Every graduate student, creative person and inventor of any stripe has experienced periods when nothing seems to come together, some of us many times. I was waist-deep in such pit after a year-long ...

Fail fast, fail cheap is a common clich in drug development. Studies project that anywhere from 4060% of potential drugs candidates fail in development due to absorption, distribution, metabolism, ...

A pioneer in the engineering of polymers for drug-delivery applications to treat diseases such as cancer and mental illness, Dr. Robert Langer has been awarded the 2015 Queen Elizabeth Prize for ...